![]() |
市场调查报告书
商品编码
1871188
柔性内视镜手术机器人市场机会、成长驱动因素、产业趋势分析及预测(2025-2034年)Flexible Endoscopic Surgery Robot Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球柔性内视镜手术机器人市场价值为 9.743 亿美元,预计到 2034 年将以 15.6% 的复合年增长率增长至 41 亿美元。

市场成长的驱动力来自对微创手术工具的激增需求、机器人技术的快速发展以及全球手术数量的不断增长。柔性内视镜手术机器人正在改变医疗保健格局,为医院、门诊中心和其他医疗机构提供先进、精准的微创治疗系统。这些机器人解决方案融合了人工智慧、成像技术和柔性机械手臂,可同时支援诊断和治疗功能,从而提高手术精度并促进患者康復。人工智慧系统、高清可视化和改进的柔性机械手臂等机器人技术的进步,使外科医生能够以更高的精度和更低的风险完成复杂的手术。此外,人口老化和慢性病负担加重导致全球手术量增加,进一步推动了产品需求。主要製造商持续加大研发投入,并积极拓展国际市场,提高了这些系统的可近性,并促进了其在医疗机构的更广泛应用。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 9.743亿美元 |
| 预测值 | 41亿美元 |
| 复合年增长率 | 15.6% |
2024年,治疗领域市占率达到58.2%,这主要归功于微创手术的日益普及以及机器人控制系统精准度的提升。人们对机器人辅助治疗的偏好不断增长,这正在重塑该领域格局,它能够提供更清晰的视野、更灵巧的操作以及更精准的导航,从而在最大限度减少创伤和加快患者康復的前提下,完成诸如肿瘤切除和组织分离等复杂手术。
2024年,泌尿外科应用领域占了41.3%的市场份额,预计到2034年将达到17亿美元。该领域市场成长的驱动力主要来自泌尿系统疾病盛行率的上升以及机器人辅助手术的广泛应用,这些技术能够提高手术精度、减少创伤并缩短住院时间。包括柔性机械手臂和人工智慧导航系统在内的技术进步,显着提高了复杂泌尿外科手术的精准度,并推动了市场的快速扩张。
2024年,北美柔性内视镜手术机器人市占率达到35.5%,这主要得益于美敦力、直觉外科和强生等产业领导者的存在。该地区的领先地位也得益于微创手术的广泛应用、有利的医保报销机制以及美国食品药物管理局(FDA)对机器人辅助系统的积极支持。胃肠道和大肠直肠疾病的高发生率,以及对技术教育和外科医生培训的持续重视,正在推动医院和手术中心迅速采用柔性机器人平台。
全球柔性内视镜手术机器人市场的主要参与者包括Intuitive Surgical、Medtronic、强生、CMR Surgical、Asensus Surgical、Medrobotics、Endo Tools Therapeutics、Endotics和GI View。为了巩固市场地位,柔性内视镜手术机器人市场的关键企业正采取一系列策略性倡议,旨在推动创新并扩大全球影响力。各公司正大力投资研发,以推出配备人工智慧精准工具和先进影像功能的下一代机器人平台。此外,各公司也透过建立合作关係和策略联盟来加强技术整合并拓展临床应用。同时,各公司也致力于获得监管部门的批准,并制定全面的培训计划,以提高外科医生对机器人的接受度。
The Global Flexible Endoscopic Surgery Robot Market was valued at USD 974.3 million in 2024 and is estimated to grow at a CAGR of 15.6% to reach USD 4.1 Billion by 2034.

Market growth is driven by the surging need for minimally invasive surgical tools, rapid advancements in robotic technology, and the growing number of surgical procedures worldwide. Flexible endoscopic surgery robots are transforming the healthcare landscape by offering hospitals, ambulatory centers, and other medical institutions advanced, precision-driven systems for minimally invasive treatments. These robotic solutions combine AI, imaging, and flexible robotic mechanisms to support both diagnostic and therapeutic functions, enhancing surgical precision and patient recovery. Progress in robotics, such as AI-enabled systems, high-definition visualization, and improved flexible arms, allows surgeons to perform complex interventions with higher accuracy and reduced risks. Additionally, the rise in global surgical procedures, spurred by an aging population and an increasing burden of chronic diseases, is further accelerating product demand. Continued investments in research and innovation, coupled with international expansion efforts by key manufacturers, are increasing accessibility and encouraging broader adoption of these systems in healthcare facilities.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $974.3 Million |
| Forecast Value | $4.1 Billion |
| CAGR | 15.6% |
In 2024, the therapeutic segment held a 58.2% share attributed to the rising acceptance of minimally invasive surgeries and enhanced precision in robotic control systems. The growing preference for robotic-assisted therapeutic interventions is reshaping the segment, offering improved visualization, superior dexterity, and refined navigation for intricate operations such as tumor excisions and tissue dissections with minimal trauma and faster patient recovery.
The urology application segment held a 41.3% share in 2024 and is projected to reach USD 1.7 Billion by 2034. Market growth in this domain is propelled by the increasing prevalence of urological disorders and the widespread integration of robotic-assisted surgeries that enhance surgical accuracy, reduce trauma, and shorten hospital stays. Technological advancements, including flexible robotic arms and AI-guided navigation systems, are significantly boosting precision in complex urological procedures and contributing to the market's rapid expansion.
North America Flexible Endoscopic Surgery Robot Market held 35.5% share in 2024, supported by the presence of leading industry participants such as Medtronic, Intuitive Surgical, and Johnson & Johnson. The region's dominance is further supported by a strong base of minimally invasive surgical procedures, favorable reimbursement frameworks, and active FDA support for robotic-assisted systems. The high prevalence of gastrointestinal and colorectal diseases, alongside the continuous focus on technological education and surgeon training, is fostering the swift adoption of flexible robotic platforms across hospitals and surgical centers.
Prominent companies active in the Global Flexible Endoscopic Surgery Robot Market include Intuitive Surgical, Medtronic, Johnson & Johnson, CMR Surgical, Asensus Surgical, Medrobotics, Endo Tools Therapeutics, Endotics, and GI View. To strengthen their position, key players in the Flexible Endoscopic Surgery Robot Market are adopting a mix of strategic initiatives aimed at driving innovation and expanding global reach. Companies are heavily investing in R&D to introduce next-generation robotic platforms equipped with AI-based precision tools and advanced imaging capabilities. Collaborative partnerships and strategic alliances are being formed to enhance technology integration and expand clinical applications. Firms are also focusing on obtaining regulatory approvals and developing comprehensive training programs to increase adoption rates among surgeons.